Chronic kidney disease-associated pruritus (CKD-aP) Program in Pharmaceutical Benefits Scheme (PBS) 012-24041207

CKD-aP restriction and item codes

Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.

PBS CKD-aP restriction and item codes

PBS Complex Drugs Programs

PBS schedule for difelikefalin

Table 1: see Table 2 in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item	Description
1	Is a hospital provider number required for an approval for PBS-subsidised difelikefalin to treat chronic kidney disease-associated pruritus (CKD-aP)? Yes. A hospital provider number: is required because difelikefalin is PBS-subsidised under Section 100 (S100) arrangements for Highly Specialised Drugs (HSD) Program must be provided for each application for S100 HSD
2	Do Service Officers have to calculate the dose and number of vials that can be approved? No. Prescribers should be requesting the number of vials required for one month’s supply at the time of approval based on the patient’s dose. Pharmaceutical Advisors (PA) can use the calculator on the master code sheet to help prescribers if they are unsure of the dose.
3	Can increased repeats be authorised for difelikefalin? No increase in the PBS-listed repeats (that is, 2 for initial treatment, and 5 for grandfather or continuing treatment) is allowed for this item.